# Etoposide

NDC: 16729-114
Generic name: Etoposide
Labeler / Manufacturer: Accord Healthcare Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20150303

FDA application: ANDA074513

## Active ingredients

- ETOPOSIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16729-114"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16729-114
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f850eb2-3542-43a0-90e8-bb37fa05cf15